StemSpine

StemSpine is a regenerative medicine company that specializes in a patented, non-surgical procedure for treating chronic back pain. The company's core technology involves the use of autologous bone marrow concentrate, which contains mesenchymal stem cells, to treat conditions such as degenerative disc disease and facet joint syndrome. Founded by spine surgeon Dr. Kenneth Pettine, StemSpine aims to provide an alternative to invasive spinal surgeries like fusion or total disc replacement. The procedure is designed to reduce pain and improve function by promoting tissue repair and reducing inflammation within the spinal environment. The company has conducted clinical research, including a Phase 2 trial, to validate the safety and efficacy of its specialized injection protocols.